Tvardi Therapeutics Inc. (TVRD) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Tvardi Therapeutics Inc.

    NASDAQ: TVRD · Real-Time Price · USD
    40.15
    -0.08 (-0.20%)
    At close: Oct 06, 2025, 10:59 AM

    Tvardi Therapeutics Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023
    Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023
    Net Income
    		 -25.57M -45.08M -70.87M -67.54M -83.09M -63.08M -32.38M -28.03M
    Depreciation & Amortization
    		 120K 150K 192K 216K 664K 587K 545K 521K
    Stock-Based Compensation
    		 707K 1.43M 3.35M 3.43M 3.43M 3.43M 85K n/a
    Other Working Capital
    		 -2.06M 782K 5.36M 1.98M 6.82M 4.44M 348K 1.87M
    Other Non-Cash Items
    		 4.38M 19.87M 21.52M 16.1M 10.35M 4.99M 3.24M 3.23M
    Deferred Income Tax
    		 n/a n/a n/a n/a n/a n/a n/a n/a
    Change in Working Capital
    		 -11.22M -11.53M -15.1M -14.83M 369K -1.77M 3.12M 4.63M
    Operating Cash Flow
    		 -31.58M -35.16M -60.92M -62.62M -68.28M -55.85M -25.39M -19.64M
    Capital Expenditures
    		 n/a -210K -1.05M -3.1M -3.42M -3.21M -2.38M -323K
    Cash Acquisitions
    		 n/a n/a n/a n/a n/a n/a n/a n/a
    Purchase of Investments
    		 -31.49M 32.21M n/a -65M -87.85M -120.06M -87.85M -22.85M
    Sales Maturities Of Investments
    		 18.55M 23M 82M 113.85M 157.68M 142.18M 83.18M 46.33M
    Other Investing Acitivies
    		 n/a -32.21M -32.21M -32.21M -32.21M n/a n/a n/a
    Investing Cash Flow
    		 -12.93M 22.79M 48.74M 13.54M 34.19M 18.9M -7.05M 23.16M
    Debt Repayment
    		 -2.31M -1.91M -3.6M 34.48M 35.18M 35.79M 36.47M n/a
    Common Stock Repurchased
    		 n/a n/a n/a n/a n/a n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a n/a n/a n/a n/a n/a
    Other Financial Acitivies
    		 22.6M -5K -5K -5K -5K n/a n/a n/a
    Financial Cash Flow
    		 20.71M -1.91M -3.6M 34.49M 36.3M 36.91M 37.59M 1.12M
    Net Cash Flow
    		 -28.59M -12.78M -14.28M -19.37M -4.07M -6.31M -1.12M 4.63M
    Free Cash Flow
    		 -31.58M -35.37M -61.96M -63.67M -69.65M -57.01M -25.72M -19.97M

    Add to Watchlist